{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:42:13Z","timestamp":1771918933417,"version":"3.50.1"},"reference-count":43,"publisher":"National Institute of Industrial Health","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ind Health"],"published-print":{"date-parts":[[2008]]},"DOI":"10.2486\/indhealth.46.535","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T05:56:07Z","timestamp":1229406967000},"page":"535-540","source":"Crossref","is-referenced-by-count":21,"title":["Asbestos-related Occupational Lung Diseases in NSW, Australia and Potential Exposure of the General Population"],"prefix":"10.2486","volume":"46","author":[{"given":"Eun-Kee","family":"PARK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty M.","family":"HANNAFORD-TURNER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"HYLAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"JOHNSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah H.","family":"YATES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-006-0091-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Christopher BM, Vallyathan V, Brooke TM (2002) Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2, 191-200.","DOI":"10.1016\/S1567-5769(01)00172-2"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2003.010165"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Bernstein DM, Hoskins JA (2006) The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol 45, 252-64.","DOI":"10.1016\/j.yrtph.2006.04.008"},{"key":"5","unstructured":"5) National Occupational Health and Safety Commission Worksafe Australia (1995) Guidance note on the interpretation of exposure standards for atmospheric contaminants in the occupational environment NOHSC 3008, 3rd Ed., Canberra."},{"key":"6","unstructured":"6) Health and Safety Executive in the United Kingdom. The control of asbestos regulations 2006. Guidance for safety representatives. www.hse.gov.uk\/asbestos. Accessed November 13, 2006."},{"issue":"2","key":"7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5271\/sjweh.186","volume":"23","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0355-3140","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Peacock C, Copley SJ, Hansell DM (2000) Asbestos-related benign pleural disease. Clin Radiol 55, 422-32.","DOI":"10.1053\/crad.2000.0450"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hessel PA, Gamble JF, McDonald JC (2005) Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. Thorax 60, 433-6.","DOI":"10.1136\/thx.2004.037267"},{"key":"10","unstructured":"10) Valeyre D, Letourneux M (1999) Asbestosis. Rev Mal Respir 16, 1294-307."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yates DH, Browne K, Stidolph P, Neville E (1996) Asbestos-related bilateral diffuse pleural thickening: a study of clinical, radiological and lung function abnormalities over time. Am J Respir Crit Care Med 153, 301-6.","DOI":"10.1164\/ajrccm.153.1.8542134"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miles S, Sandrini A, Johnson A, Yates DH (2008) Clinical consequences of asbestos related diffuse pleural thickening: a review. J Occup Med Toxicol (in press).","DOI":"10.1186\/1745-6673-3-20"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0274(200002)37:2<159::AID-AJIM1>3.0.CO;2-0"},{"key":"14","unstructured":"14) Governa M, Amati M, Bellis D, Bichisecchi E, Santarelli L (2006) Diagnosis of asbestos-related pleuropolmonary diseases. Med Lav 97, 463-74."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Howel D, Gibbs A (1999) Mineral fiber analysis and routes of exposure to asbestos in the development of mesothelioma in an English region. Occup Environ Med 56, 51-8.","DOI":"10.1136\/oem.56.1.51"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zellos L, Christiani DC (2004) Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin 14, 479-87.","DOI":"10.1016\/j.thorsurg.2004.06.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Metintas S, Metintas M, Ucgun I, Oner U (2002) Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest 122, 2224-9.","DOI":"10.1378\/chest.122.6.2224"},{"key":"18","unstructured":"18) Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6, 162-6."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J (2005) The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 92, 587-93.","DOI":"10.1038\/sj.bjc.6602307"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ryan CW, Herndon J, Vogelzang NJ (1998) A review of chemotherapy trials for malignant mesothelioma. Chest 113 (Suppl 1), 66S-73S.","DOI":"10.1378\/chest.113.1_Supplement.66S"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Martino D, Pass HI (2004) Integration of multimodality approaches in the management of malignant pleural mesothelioma. Clin Lung Cancer 5, 290-8.","DOI":"10.3816\/CLC.2004.n.008"},{"issue":"4","key":"22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5271\/sjweh.1145","volume":"33","author":"HYLAND REBECCA A","year":"2007","ISSN":"https:\/\/id.crossref.org\/issn\/0355-3140","issn-type":"print"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.10047"},{"key":"24","unstructured":"24) Australian Government National Occupational Health and Safety Commission (2004) The incidence of mesothelioma in Australia 1999 to 2001-Australian Mesothelioma Register Report 2004, Canberra."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Clements M, Berry G, Shi M, Ware S, Yates DH, Johnson AR (2007) Projected mesothelioma incidence in men in NSW. Occup Environ Med 64, 747-52.","DOI":"10.1136\/oem.2006.031823"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690105"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Eng J Med 353, 1591-603.","DOI":"10.1056\/NEJMra050152"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Price B (1997) Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145, 211-8.","DOI":"10.1093\/oxfordjournals.aje.a009093"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh025"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Carbone M, Albelda SM, Broaddus VC, Flores RM, Hillerdal G, Jaurand M-C, Kjaerheim K, Pass HI, Robinson B, Tsao A (2007) Eighth international mesothelioma interest group. Oncogene 26, 6959-69.","DOI":"10.1038\/sj.onc.1210515"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sugarbaker DJ, Norberto JJ (1998) Multimodality management of malignant pleural mesothelioma. Chest 113 (Suppl 1), 61S-65S.","DOI":"10.1378\/chest.113.1_Supplement.61S"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.37.271"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.45.379"},{"key":"34","unstructured":"34) Musk AW, de Klerk NH (2004) Epidemiology of malignant mesothelioma in Australia. Lung Cancer 45 (Suppl1), 21-3."},{"key":"35","unstructured":"35) News.com.au (2006) Asbestos threat played down. http:\/\/www.news.com.au\/story\/0,10117,18391405-29277,00.html. Accessed March 8, 2006."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Allan TM (1965) An autumn peak of lung-cancer deaths. Lancet 2, 387-8.","DOI":"10.1016\/S0140-6736(65)90366-1"},{"key":"37","unstructured":"37) The Surveillance of Australian Workplace Based Respiratory Events (SABRE) scheme. www.sabrensw.org. Accessed January 1, 2001."},{"key":"38","unstructured":"38) The Workers&#39; Compensation Dust Diseases Board. The Annual report 2002-2003 and 2005-2006, Sydney, NSW, Australia. http:\/\/www.ddb.nsw.gov.au. Accessed July 1, 2003."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Cocchiarella L, Andersson GBJ (Eds.) (2001) The Guides to the evaluation of permanent impairment, 5th Ed., American Medical Association, Press, Chicago, ILL.","DOI":"10.1001\/978-1-57947-085-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) American Thoracic Society (2004) Diagnosis and initial management of non-malignant diseases related to asbestos. Am J Respir Crit Care Med 170, 691-715.","DOI":"10.1164\/rccm.200310-1436ST"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tossavainen A (1997) Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scan J Work Environ Health 23, 311-6.","DOI":"10.5271\/sjweh.226"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Gibbs A, Attanoos RL, Churg A, Weill H (2007) The &#8220;Helsinki Criteria&#8221; for attribution of lung cancer to asbestos exposure: how robust are the criteria? Arch Pathol Lab Med 131, 181-3.","DOI":"10.5858\/2007-131-181-THCFAO"},{"key":"43","unstructured":"43) Hannaford-Turner KM, Ellis AJ, Boadle R, Glanville A, Johnson AR, Yates DH (2007) Asbestos concentrations and fiber type in lung tissue of NSW residents. Respirology 12 (Suppl 4), A219 (abstract)."}],"container-title":["Industrial Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/indhealth\/46\/6\/46_6_535\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T23:33:20Z","timestamp":1684798400000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/indhealth\/46\/6\/46_6_535\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.2486\/indhealth.46.535","relation":{},"ISSN":["0019-8366","1880-8026"],"issn-type":[{"value":"0019-8366","type":"print"},{"value":"1880-8026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}